In 1951 a young mother in the USA, Henrietta Lacks, was treated for cancer of the cervix. Without asking her, doctors kept a sample of her tumor, and its cells did something no human cells had done before: they kept dividing in a dish, generation after generation. Henrietta died that year, aged 31, but her cells, named HeLa cells after her, are still alive in laboratories all over the world. They were used to test the first polio vaccine, to grow viruses, and to study cancer, HIV and many other diseases, and more than 10,000 patents have been based on work with them. Her cells are immortal for a reason this unit explains: her cancer was caused by a virus, the human papillomavirus (HPV), against which girls in Nepal are now vaccinated in Grade 6.
This unit is about the microbes that make us ill. It sorts them by how dangerous they are, and how laboratories handle each group; it follows seven diseases common in Nepal from the microbe that causes each to how it spreads, how it is found and how it is treated; and it ends with the body’s own defenses and the vaccines that train them.
Microbial diseases
The WHO defines health as “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity”. Any change from this healthy state, of the body, of the mind or in a person’s life with others, that causes discomfort, disability or harm is a disease. Diseases have many causes: faulty genes, a poor diet, injury, harmful habits, and microbes. A disease caused by microorganisms (microbes) is a microbial disease.
Most microbes are harmless, and many are useful: the bacteria in curd, the yeast in bread, the billions of bacteria in your gut that make vitamins and crowd out harmful ones. A microbe that causes disease is a pathogen. Some pathogens cause mild illness that is easily treated; others cause serious or deadly disease that spreads easily. To work with them safely, scientists sort them by how dangerous they are.
1. Risk and hazard groups of microorganisms
Two everyday words have precise meanings here.
- A hazard is anything that could cause harm. A pathogen in a test tube is a hazard.
- Risk is the chance, high or low, that the hazard actually harms someone. A tube of a dangerous pathogen, sealed in a locked fridge, is a hazard with a low risk; the same pathogen spilled on a bench is a high risk.
So a laboratory asks two questions of every microbe: how harmful is it, and how likely is it to reach a person?
Risk groups
The WHO’s Laboratory Biosafety Manual sorts microorganisms into four risk groups (RG) by four questions: does it cause disease in people, how serious is the disease, how easily does it spread from person to person, and are there vaccines and treatments?
I. Risk group 1 (RG-1): microorganisms unlikely to cause disease in healthy people or animals. No or low risk to the worker and to the community. Examples: the bacteria Escherichia coli K-12 (a harmless laboratory strain), Lactobacillus acidophilus (in curd) and Bacillus subtilis; the mold Aspergillus niger; baker’s yeast, Saccharomyces cerevisiae.
II. Risk group 2 (RG-2): pathogens that can cause disease, but are unlikely to be a serious hazard: lab exposure may cause infection, but effective treatment and prevention are available and the risk of spread in the community is limited. Examples: influenza viruses, rotavirus and herpes simplex virus; the bacterium Streptococcus pneumoniae; the fungi Aspergillus flavus and Candida albicans; the protozoa Plasmodium vivax and Leishmania donovani; and the eggs and larvae of parasitic worms: flatworms (lung fluke, blood fluke, tapeworm, hydatid worm) and roundworms (filarial worm, eye worm).
III. Risk group 3 (RG-3): pathogens that usually cause serious disease, but effective treatment and preventive measures are available, and which don’t ordinarily spread from one infected person to another by casual contact. Examples: hepatitis B and C viruses, HIV and the SARS coronavirus; the bacteria Mycobacterium tuberculosis, Salmonella Typhi and Yersinia pestis (plague); the fungus Blastomyces dermatitidis.
IV. Risk group 4 (RG-4): pathogens that cause serious, often deadly disease, spread readily from person to person, and for which effective treatment and prevention are usually not available. Examples: Ebola, Marburg and Lassa viruses.
Biosafety levels
A risk group describes the microbe; a biosafety level (BSL) describes the laboratory: the building, equipment and practices needed to work with it safely. How much containment a lab needs depends on the microbe’s infectivity (how easily it infects), the severity of its disease, its transmissibility (how easily it spreads), and the kind of work being done (growing large amounts is riskier than looking at a slide). There are four levels, and each risk group is normally handled at the matching level:
- BSL-1 for RG-1: an ordinary teaching lab with an open bench, good handwashing, no eating or drinking.
- BSL-2 for RG-2: lab coats and gloves, a biosafety cabinet for anything that makes splashes or droplets, an autoclave nearby, limited entry. Most hospital labs in Nepal work at this level.
- BSL-3 for RG-3: a sealed lab entered through two doors, air drawn inwards and filtered before it leaves, all work in biosafety cabinets, workers in respirators.
- BSL-4 for RG-4: a sealed building or a separate zone with its own air and waste treatment; workers in full-body pressurized suits breathing air piped in, or work done inside sealed glove boxes.
Six kinds of hazard
The hazards in human life, at work and at home, are of six kinds:
- Biological hazards: living things and their products that can harm people: microorganisms, blood and body fluids, harmful plants, sewage, some dusts, and vermin such as rats and cockroaches.
- Chemical hazards: substances that irritate the skin or the airways, blind, corrode, poison or explode: acids, pesticides, solvents, gases.
- Physical hazards: high altitude, noise, radiation, extreme pressure, heat and cold.
- Safety hazards: things that cause accidents: broken furniture, exposed wires, wet floors, unguarded machines.
- Ergonomic hazards: strain from a poor office setup, poor posture, lifting heavy loads or repeating the same movement for hours.
- Psychosocial hazards: stress, sexual harassment, bullying and victimization, workplace violence.
Biological hazards come from biological agents: toxins, allergens, cancer-causing agents and microbes. The microbes that cause disease, the pathogens, are of five kinds: viruses, bacteria, fungi, protozoa and a few worms: flatworms such as the blood fluke and tapeworm, and roundworms such as the filarial worm and the eye worm. The diseases they cause are pathogenic diseases.
Hazard groups
Some countries, among them the United Kingdom, sort human pathogens into four hazard groups (HG) by four questions: can it infect people, how severe is the disease, is it likely to spread in the community, and is effective prophylaxis (prevention, such as a vaccine) or treatment available?
| Group | Disease in people | Spread to the community | Prevention or treatment |
|---|---|---|---|
| HG-1 | unlikely to cause disease | (none) | (not needed) |
| HG-2 | can cause disease; may be a hazard to workers | unlikely | usually available |
| HG-3 | can cause severe disease; a serious hazard to workers | may spread | usually available |
| HG-4 | causes severe disease; a serious hazard to workers | likely to spread | usually not available |
Put together, the three scales line up: BSL-1 is for RG-1 microbes or HG-1 pathogens, BSL-2 for RG-2 or HG-2, BSL-3 for RG-3 or HG-3 and BSL-4 for RG-4 or HG-4.
A pathogen causes severe disease and may spread in the community, but a vaccine and drugs for it exist. Which group and which laboratory?
Pick an answer to see why.
Which is a risk, not a hazard?
Pick an answer to see why.
2. Human microbial diseases
A human microbial disease is an illness caused by a pathogen that gets into the body and multiplies there (an infection). The commonest pathogens are viruses, bacteria, fungi and protozoa.
How diseases spread
Every infection is a chain. The pathogen lives somewhere, its reservoir (an infected person, a carrier who isn’t ill, an animal, soil or water); it leaves by a way out (coughs, feces, blood); it travels by a mode of transmission (MoT); it enters a new person by a way in (the nose, the mouth, a cut, a mosquito’s bite); and it infects that person if he or she is susceptible, not immune. Break any link, and the disease stops spreading.
The mode of transmission is of two kinds.
- Direct transmission, straight from one person to another: contact (touching, kissing, sexual contact), droplet infection (droplets from a cough, a sneeze or speech, which fall within about 1–2 meters), and from mother to baby across the placenta, at birth or in breast milk.
- Indirect transmission, through something in between: vehicles (contaminated food, water, blood, needles and objects such as towels), vectors (living carriers such as mosquitoes, flies and ticks), and air (tiny dried droplets, droplet nuclei, that float for hours, as with TB).
Words that describe a disease
Doctors describe each disease by a set of labels. Each label answers a question.
| Question | Labels | Meaning |
|---|---|---|
| Body or mind? | physical / mental | a physical disease harms the body’s organs; a mental one, thinking, mood and behavior |
| Born with it? | congenital / acquired | congenital: present at birth (from the mother in the womb, or in the genes); acquired: caught after birth |
| Does it spread? | communicable / non-communicable | communicable (infectious, contagious when by contact): passes from one host to another; non-communicable: does not |
| How common, and where? | endemic | always present in a region at a steady level (typhoid in Nepal) |
| epidemic | many more cases than usual in a region at one time (a cholera outbreak in Kathmandu in the monsoon) | |
| pandemic | an epidemic that spreads across several continents (COVID-19 in 2020; cholera in seven waves since 1817) | |
| sporadic | a few scattered cases now and then | |
| In animals? | enzootic / epizootic | always present in animals of a region / an outbreak in animals (bird flu in poultry farms) |
| zoonotic (a zoonosis) | caught by people from animals (rabies, bird flu, Ebola from bats) | |
| How it travels | air-borne, water-borne, food-borne, vector-borne, blood-borne | by droplets and air; in water; in food; by a living carrier; in blood and body fluids |
Two more: a carrier is a person who carries and spreads a pathogen without being ill, and a disease whose only reservoir is people is a human-carrier (anthroponotic) disease, as typhoid and cholera are.
Bird flu (H5N1) passes to a person from a sick hen. The disease in the person is:
Pick an answer to see why.
Some microbial diseases are mild, others very serious, and some of each kind are described in this unit: influenza, hepatitis, HIV/AIDS, typhoid, tuberculosis, cholera and candidiasis. All seven are physical, acquired and communicable. (Some cancers are also started by microbes: cervical cancer by HPV, liver cancer by hepatitis B and C. The virus spreads, but the cancer itself does not.)
I. Influenza
Introduction. Influenza (“flu”, once called grippe; रुघाखोकी, rughakhoki in Nepali speech, though a common cold is milder) is an acute viral infection of the airways, the nose, throat and lungs, marked by a sudden fever, chills, aching muscles and great tiredness, often with a headache. It can be mild or severe. In Nepal it is commonest in winter, with a second rise in the monsoon, but it can occur in any season.
Description. Influenza is a physical disease (it harms the airways), acquired, and communicable: an air-borne disease spread by droplets from person to person. It is endemic, with epidemics every year, and it becomes pandemic when a new kind of virus appears to which nobody is immune. The influenza A viruses are also enzootic in wild water birds and pigs, and some of their strains are zoonotic.
Epidemiology. An epidemic like influenza may have reached the Americas with Columbus’s second voyage in 1493, killing much of the people of the Antilles. The first convincing record of a pandemic is from 1510, spreading from Asia through Africa into Europe. The worst came in 1918, the “Spanish flu”, which killed perhaps 50 million people; others followed in 1957, 1968 and 2009 (“swine flu”). Pandemics come irregularly, a few times a century, whenever a new influenza A virus appears; between them, seasonal flu infects about a billion people a year worldwide and kills about 290,000 to 650,000, mostly the old (WHO).
People at high risk of severe flu: children under 5 (most of all under 6 months), adults over 65, people in nursing homes and other long-term care, pregnant women and women up to two weeks after giving birth, people with weak immune systems, people with long-term heart, kidney, liver or lung disease (asthma), diabetes, and severe obesity.
Causative agent. Influenza viruses, RNA viruses of the family Orthomyxoviridae. Each has an envelope studded with two kinds of spike, hemagglutinin (H), which lets it stick to and enter cells, and neuraminidase (N), which frees new viruses from the cell; inside are eight separate pieces of RNA. There are four types:
- Influenza A: infects people, birds, pigs and other animals; named by its spikes, H1N1, H3N2 and so on. A and B cause the yearly epidemics; only A has caused pandemics.
- Influenza B: people only; two lineages, B/Victoria and B/Yamagata.
- Influenza C: mild colds, mostly in children.
- Influenza D: cattle; not known to make people ill.
Influenza A virion: after ViralZone, SIB Swiss Institute of Bioinformatics, CC BY 4.0, viralzone.expasy.org
Mode of transmission. Direct, from person to person, mainly by droplets made when someone with flu coughs, sneezes or talks; they land in the mouths or noses of people up to about 2 meters away, or are breathed into the lungs. The virus also survives for hours on hands, door handles and phones, and is carried from there to the eyes, nose and mouth.
Incubation period. About 2 days on average, ranging from 1 to 4 days.
Signs and symptoms. Unlike a common cold, flu starts suddenly: fever, aching muscles, chills and sweats, headache, a dry persistent cough, sore throat, a runny or stuffy nose, shortness of breath, tiredness and weakness, eye pain, and, in children, vomiting and diarrhea.
Effects. The virus damages the lining of the nose, throat and airways. Most people recover in one to two weeks. Its complications are pneumonia (often from bacteria invading the damaged lungs), bronchitis, flare-ups of asthma, heart problems, ear and sinus infections, and acute respiratory distress syndrome (ARDS).
Diagnosis. Usually from the symptoms during the flu season. To be sure, a nose or throat swab is tested by RT-PCR (which finds the virus’s RNA), by viral culture, or by immunofluorescence and rapid antigen tests (which find its proteins).
Prevention. Wash hands often with soap; avoid touching the face; cover coughs and sneezes with the elbow; clean surfaces often touched; avoid crowds in a flu season, and stay home when ill; wear a mask; and the yearly flu vaccine, changed each year to match the strains about.
Treatment. Rest, fluids and paracetamol for the fever. Antiviral drugs, given by a doctor to people at high risk, work best within two days of the first symptom: oseltamivir (Tamiflu), zanamivir (Relenza), peramivir (Rapivab) and baloxavir. Antibiotics don’t act on viruses.
Why does the influenza vaccine have to be changed every year?
Pick an answer to see why.
II. Hepatitis
Hepatitis is inflammation of the liver (hepar, liver; -itis, inflammation), of its working tissue, the parenchyma. Alcohol, some drugs and poisons can cause it, but most is caused by viruses, five of them, named hepatitis A, B, C, D and E viruses (HAV, HBV, HCV, HDV and HEV). In Nepal it is called कलेजोको रोग (kalejoko rog) or, for its yellowing, कमलपित्त (kamalpitta, jaundice); in Sanskrit, यकृत् शोथ (yakrit shotha, swelling of the liver).
All five cause the same illness at first, acute hepatitis: fever, tiredness, loss of appetite, nausea, pain under the right ribs, dark urine and jaundice, the yellowing of the skin and the whites of the eyes. (A damaged liver can’t clear bilirubin, a yellow pigment made from old red blood cells, so it builds up in the blood.) But they differ in how they spread, and above all in whether they stay: A and E are cleared, while B, C and D can become chronic, lasting for life and slowly scarring the liver (cirrhosis) or causing liver cancer.
In 2022, an estimated 254 million people lived with hepatitis B and 50 million with hepatitis C, and viral hepatitis killed about 1.3 million people, as many as tuberculosis (WHO, 2024). The WHO’s strategy, agreed by all its member states, aims to cut new infections by 90% and deaths by 65% between 2016 and 2030; vaccines, tests, medicines and awareness could prevent about 4.5 million early deaths in low- and middle-income countries by then. 28 July is World Hepatitis Day, the birthday of Baruch Blumberg, who discovered the hepatitis B virus.
| Hepatitis A | Hepatitis B | Hepatitis C | Hepatitis D | Hepatitis E | |
|---|---|---|---|---|---|
| Other names | infectious hepatitis, epidemic jaundice, travelers’ hepatitis | serum hepatitis | (once “non-A, non-B”); the “silent killer” | delta hepatitis | enteric (waterborne) non-A hepatitis |
| Virus | HAV, RNA | HBV, DNA | HCV, RNA | HDV, RNA, incomplete: needs HBV | HEV, RNA |
| Spread | feces to mouth (food, water, close contact) | blood, sex, mother to baby at birth | blood (needles, unclean tools); rarely sex or mother to baby | blood, sex; only with HBV | feces to mouth, mainly water |
| Incubation | 2–7 weeks (usually 2–4) | 1–6 months (average about 2½) | 2 weeks to 6 months | like HBV, about 1–6 months | 2–10 weeks (usually 5–6) |
| Becomes chronic? | no | yes, in 90% of infected newborns, under 5% of adults | yes, in about 70% | yes, often | no (except in people with weak immunity) |
| Cirrhosis, liver cancer | no | yes | yes | yes, fastest | no |
| Vaccine | yes | yes (also protects against D) | no | the hepatitis B vaccine | yes (in China) |
| Treatment | rest, care | antivirals keep it in check | antivirals cure it | limited | rest, care |
i. Hepatitis A
Introduction and description. A viral disease also called infectious hepatitis, epidemic jaundice or travelers’ hepatitis. Physical, acquired, communicable and contagious, endemic in places with poor sanitation, with epidemics from a dirty water supply.
Epidemiology. Outbreaks of jaundice that were probably hepatitis A were recorded in the 17th and 18th centuries, especially among armies on campaign. In the 1940s doctors showed there were two kinds, “infectious” hepatitis (A) caught through the mouth and “serum” hepatitis (B) through blood; the virus itself was first seen in 1973. In Nepal, as in other places where hepatitis A is common, most people catch it as young children, when it is usually mild or silent, and are then immune for life; it is preventable by vaccination. Risk factors: poor sanitation and unsafe water, living with an infected person, sexual contact with someone with acute hepatitis A, using injected drugs, and traveling unvaccinated to a place where it is common.
Causative agent. Hepatitis A virus (HAV), an RNA virus without an envelope, tough enough to survive in water.
Causes and mode of transmission. Eating food or drinking water contaminated with an infected person’s feces (the feco-oral route), and close contact: living in the same house, sexual contact, rarely shared needles.
Incubation period. 15 to 50 days, usually 2 to 4 weeks.
Signs and symptoms. Mild to severe: fever, malaise (feeling unwell), loss of appetite, diarrhea, nausea, abdominal discomfort, dark urine and jaundice. Young children often have none.
Effects. HAV inflames the liver for a few weeks; almost everyone recovers completely, and it never becomes chronic or causes cirrhosis. Very rarely it causes sudden liver failure, more often in older adults.
Diagnosis. A blood test for IgM antibodies against HAV (anti-HAV IgM, a new infection; IgG shows past infection or vaccination), or RT-PCR for its RNA in blood or stool.
Prevention. Clean water, safe food, hand washing and toilets; the hepatitis A vaccine.
Treatment. No drug kills the virus; rest, food and fluids, and avoiding alcohol and drugs that strain the liver, while the body clears it.
ii. Hepatitis B
Introduction and description. A viral disease once called serum hepatitis, because it spreads in blood. It is 50 to 100 times more infectious than HIV: a tiny trace of blood on a razor or a needle can pass it on. Physical, acquired, communicable; endemic worldwide, with outbreaks in particular groups.
Epidemiology. In 1965 the American doctor Baruch Blumberg found an unknown protein in the blood of an Australian Aboriginal man; it turned out to be part of the hepatitis B virus (its surface antigen), and it led to a blood test and, in 1981, the first vaccine. He shared the 1976 Nobel Prize. In 1986 the hepatitis B vaccine became the first vaccine made by genetic engineering. Chronic hepatitis B, with C, is the commonest cause of cirrhosis, liver cancer and deaths from viral hepatitis; most people with it don’t know they have it, and for many, testing and treatment are still out of reach. Risk factors: contact with an infected person’s blood, semen or vaginal fluid: unprotected sex, sharing needles or drug-injection equipment, unclean medical, dental, tattooing and piercing tools, and being born to an infected mother.
Causative agent. Hepatitis B virus (HBV), a small DNA virus. The whole virus is the Dane particle (named after David Dane, who saw it in 1970). It carries three antigens that tests look for: the surface antigen (HBsAg) on its envelope, the core antigen (HBcAg) of its capsid, and the e antigen (HBeAg), released while the virus is multiplying fast.
Causes and mode of transmission. Parenteral (through the skin, by blood: needles, transfusions of unscreened blood, razors, toothbrushes), sexual (blood, semen, other body fluids) and from mother to baby at birth.
Incubation period. 30 to 180 days, on average about 75 days (2½ months).
Signs and symptoms. Many have none. Others: fever, tiredness, loss of appetite, nausea and vomiting, abdominal pain, dark urine, pale, clay-colored stools, and jaundice.
Effects. HBV attacks the liver cells; the immune system’s attack on the infected cells causes the inflammation. The younger the person infected, the likelier it stays: 90% of infected newborns become chronic carriers, against fewer than 5% of adults; over years chronic infection can lead to cirrhosis and liver cancer. Drinking alcohol speeds the damage.
Diagnosis. A blood test for HBsAg (it means a current infection), with others (anti-HBc, HBV DNA) to tell new from chronic.
Prevention. The hepatitis B vaccine, given to babies in Nepal in the pentavalent vaccine at 6, 10 and 14 weeks (see the table under Vaccines); screening donated blood; safe sex and condoms; never sharing needles, razors or toothbrushes; sterile tools in clinics and tattoo shops.
Treatment. Antiviral drugs (tenofovir, entecavir), taken for years, keep the virus down and protect the liver, though they rarely clear it.
iii. Hepatitis C
Introduction and description. A viral disease called the silent killer, because most people have no symptoms for decades while their liver is slowly scarred. Physical, acquired, communicable, spread from blood to blood: a human-carrier disease, with silent epidemics among people who inject drugs.
Epidemiology. Until 1989 it was known only as “non-A, non-B hepatitis” that followed blood transfusions; that year the virus was identified, which won Harvey Alter, Michael Houghton and Charles Rice the 2020 Nobel Prize. About 50 million people live with chronic hepatitis C (2022). Risk factors: infected blood (transfusions before blood was screened), sharing needles, tattoos and piercings with unsterilized needles, and, less often, sex.
Causative agent. Hepatitis C virus (HCV), an RNA virus with an envelope.
Causes and mode of transmission. Blood-to-blood contact: shared needles and syringes, unsterilized medical tools, razors and toothbrushes, unscreened blood; from mother to baby at birth; rarely sexual contact. It does not spread through food or water, hugging or sharing meals.
Incubation period. 2 weeks to 6 months, on average 6 to 9 weeks.
Signs and symptoms. Most have none at first. When the liver is badly damaged: bleeding and bruising easily, tiredness, poor appetite, jaundice, dark urine, itchy skin, swollen legs and ascites (fluid collecting in the abdomen).
Effects. About 70% of those infected become chronic; over 20 to 30 years, some develop cirrhosis and liver cancer. Alcohol speeds this.
Diagnosis. A blood test for antibodies (anti-HCV), then RT-PCR for HCV RNA to show the virus is still there.
Prevention. No vaccine exists. Screening blood, sterile needles and tools, never sharing needles, razors or toothbrushes, and safe sex.
Treatment. Since 2014, direct-acting antiviral tablets taken for 8 to 12 weeks cure more than 95% of people: one of the great medical advances of this century.
A tattoo artist reuses a needle without sterilizing it. Which two hepatitis viruses is a customer most at risk of?
Pick an answer to see why.
iv. Hepatitis D
Introduction and description. A viral disease that affects only people who also have hepatitis B, in either of two ways: caught together with HBV (co-infection), or caught by someone who already carries HBV (superinfection), which is the more dangerous. Physical, acquired, communicable, blood-borne; endemic in parts of Africa, Asia, the Mediterranean and South America.
Epidemiology. Discovered in Italy in 1977 by Mario Rizzetto. It infects about 5% of people with chronic hepatitis B, and hepatitis D with B together is the most severe form of chronic viral hepatitis, leading fastest to cirrhosis, liver failure and liver cancer. Risk factors: chronic hepatitis B, injecting drugs, unsafe sex, HIV infection, and living where both viruses are common.
Causative agent. Hepatitis D virus (HDV, the delta agent), a tiny RNA virus that is incomplete: it can’t make its own envelope, and borrows HBV’s surface antigen (HBsAg) to make its coat. Without HBV it cannot spread.
Causes and mode of transmission. Like HBV: blood and body fluids, sexual contact, and rarely from mother to baby.
Incubation period. About 1 to 6 months (3 to 7 weeks in a superinfection).
Signs and symptoms. Jaundice, stomach upset, belly pain, vomiting, tiredness, loss of appetite, joint pain and dark urine.
Effects. Faster and more severe liver damage than hepatitis B alone.
Diagnosis. Blood tests for anti-HDV antibodies and RT-PCR for HDV RNA, in anyone with HBsAg.
Prevention. Since HDV can’t exist without HBV, the hepatitis B vaccine prevents hepatitis D too. Screening blood and safe practices as for B.
Treatment. Limited: injections of interferon for a year, and since 2020 in Europe a new drug, bulevirtide, which blocks the virus from entering liver cells.
v. Hepatitis E
Introduction and description. A viral disease spread through dirty water, especially dangerous for pregnant women. Physical, acquired, communicable, water-borne; endemic in South Asia, with large epidemics when sewage gets into the water supply.
Epidemiology. It was proven to be a separate virus in 1983, when a Soviet scientist, Mikhail Balayan, swallowed an extract of stool from patients in an outbreak in Afghanistan, fell ill himself, and found the virus in his own stool. About 20 million infections occur each year worldwide. In most people it is mild, but in the last three months of pregnancy it can be fatal in up to 1 in 5 cases. Risk factors: poor sanitation and unsafe water, raw or undercooked pork or deer meat, and weak immunity.
Causative agent. Hepatitis E virus (HEV), an RNA virus.
Causes and mode of transmission. The feco-oral route, mainly through drinking water contaminated with feces, especially after floods and in the monsoon; also undercooked meat from infected animals.
Incubation period. 2 to 10 weeks, usually 5 to 6 weeks.
Signs and symptoms. Fever, tiredness, loss of appetite, nausea and vomiting, abdominal pain, jaundice and dark urine.
Effects. Usually clears in a few weeks with no lasting harm; in pregnant women it can cause sudden liver failure. Only in people with very weak immunity (after an organ transplant) can it become chronic.
Diagnosis. Blood tests for anti-HEV antibodies (IgM) and RT-PCR for HEV RNA in blood or stool.
Prevention. Safe drinking water (boiled, filtered or chlorinated), toilets and sewage kept away from water sources, hand washing, and well-cooked meat. A vaccine is licensed in China.
Treatment. No specific drug; rest, fluids and care, in hospital for pregnant women.
Why does a vaccine against hepatitis B also protect against hepatitis D?
Pick an answer to see why.
III. HIV/AIDS
Introduction. AIDS, acquired immunodeficiency syndrome, is the late stage of infection by HIV, the human immunodeficiency virus, and the two together are called HIV/AIDS. HIV destroys the helper T cells, also called CD4 cells after the CD4 protein on their surface, the cells that direct the rest of the immune system. Without them the body can no longer fight infections it would normally beat.
Description. HIV/AIDS is acquired, and it can also pass from mother to baby, so a baby can be born with it. It is communicable, a blood-borne and sexually transmitted disease whose only reservoir is people, and it is a pandemic: it has spread to every country. It is a physical disease, of the blood’s white cells and the whole immune system. 1 December is World AIDS Day.
Epidemiology. AIDS was first described in the USA in 1981, in young men who fell ill with rare infections. In 1983 Françoise Barré-Sinoussi and Luc Montagnier at the Pasteur Institute in Paris found the virus, which they called lymphadenopathy-associated virus (LAV); in 1984 Robert Gallo’s team in the USA called it HTLV-III. In 1986 an international committee of virologists named it HIV. Barré-Sinoussi and Montagnier won the 2008 Nobel Prize. The virus came from chimpanzees in Central Africa, passing to people early in the 20th century.
At the end of 2025 about 41 million people lived with HIV; 1.2 million were newly infected that year and about 570,000 died of AIDS-related illnesses (UNAIDS, 2026), far fewer than at the peak in 2004, when 2.1 million died, thanks to treatment. In Nepal testing for HIV began in 1986, and the first case was diagnosed in 1988. The epidemic here is concentrated: most infections are in a few groups at higher risk, such as people who inject drugs, sex workers and their clients, and migrant workers, rather than spread across the whole population. About 34,000 people lived with HIV in Nepal at the end of 2024, of whom about 26,000 were on treatment; new infections fell by three quarters from 2010 to 2024, from about 2,600 to about 600 a year (National Centre for AIDS and STD Control, 2025).
Risk factors. Unprotected sex, sharing needles and syringes, infected blood and blood products, and being born to or breastfed by a mother with untreated HIV.
Which body fluids carry HIV. Blood, semen and pre-seminal fluid, vaginal and rectal fluids, and breast milk carry enough HIV to infect. Sweat, tears, saliva and urine don’t: HIV is not passed on by hugging, shaking hands, sharing food or a toilet, kissing, coughs, or mosquito bites.
Causative agent. HIV, a retrovirus of the genus Lentivirus: an enveloped virus with two copies of single-stranded RNA and the enzyme reverse transcriptase, which copies its RNA into DNA (the reverse of the usual direction, hence “retro”). Its envelope spikes, gp120 and gp41, fit the CD4 protein on helper T cells and a second receptor beside it. There are two kinds: HIV-1, found worldwide and responsible for most infections, and HIV-2, mainly in West Africa and less easily spread.
HIV virion: after ViralZone, SIB Swiss Institute of Bioinformatics, CC BY 4.0, viralzone.expasy.org
How HIV infects a helper T cell
- Attachment: gp120 binds to CD4 and then to a second receptor (CCR5 or CXCR4) on the helper T cell.
- Fusion and entry: gp41 pulls the virus’s envelope into the cell membrane; they fuse, and the capsid enters.
- Reverse transcription: reverse transcriptase copies the RNA into DNA.
- Integration: the enzyme integrase inserts the viral DNA into the cell’s own chromosome, where it stays for the cell’s life (a provirus).
- Making new parts: the cell, its machinery hijacked, makes viral RNA and proteins.
- Assembly and budding: new viruses bud from the membrane, taking a piece of it as their envelope; the enzyme protease cuts their proteins into working shape, and they go on to infect other cells. The T cell dies.
Mode of transmission. Direct:
- Sexual contact: the commonest route worldwide. The chance per act is low, about 0.08% (8 in 10,000) for a woman in vaginal sex with an infected man, and higher for anal sex (about 1.4%); it rises when either partner has another sexually transmitted infection, and falls almost to zero when the partner with HIV is on treatment.
- Blood: a transfusion of infected blood passes HIV in more than 90% of cases, which is why all donated blood is screened. Sharing a needle with someone who has HIV passes it in about 0.6% of injections, but people who inject drugs share needles many times, so HIV spreads quickly among them.
- Mother to baby (vertical transmission): in pregnancy, at birth or in breast milk; without treatment, about 15 to 45% of babies of mothers with HIV are infected; with treatment, fewer than 2%.
Incubation period. The first illness, if any, comes 2 to 6 weeks after infection. But it takes on average about 10 years without treatment for HIV to destroy enough CD4 cells to cause AIDS.
Signs, symptoms and stages. Untreated, HIV infection goes through four stages.
- Acute (primary) infection, 2 to 6 weeks after infection: a flu-like illness, with fever, headache, rash and sore throat, which passes. The virus multiplies fast and the person is very infectious. For the first weeks the body hasn’t yet made enough antibodies to show in a test: this is the window period, from about 2 weeks to 3 months, when an antibody test is negative but the person can pass HIV on.
- Clinical latency (asymptomatic stage): years with no symptoms except swollen lymph nodes (generalized lymphadenopathy). The antibody test is now positive. The virus is quietly destroying CD4 cells all the while.
- Symptomatic stage (once called the AIDS-related complex, ARC): unexplained fever for more than a month, diarrhea for more than a month, and losing more than 10% of body weight; this wasting earned AIDS the name slim disease in Uganda.
- AIDS (the end stage): fewer than 200 CD4 cells per microliter of blood (healthy people have 500 to 1,500), and opportunistic infections: infections that a healthy immune system keeps away, such as tuberculosis, Pneumocystis pneumonia, oral and esophageal candidiasis, Mycobacterium avium infection, and some cancers (Kaposi’s sarcoma). Tuberculosis is the leading cause of death among people with HIV.
Effects. As helper T cells are destroyed, B cells make fewer antibodies and killer T cells aren’t called up, so the whole immune system is weakened and the person falls prey to TB, pneumonia, fungal infections and cancers.
Diagnosis. A screening test finds antibodies (and in newer tests the virus’s p24 protein as well) in blood: ELISA, or rapid tests that give an answer in 20 minutes. Nepal confirms a positive result with three different rapid tests in turn. The Western blot test was long used to confirm HIV; it has now mostly been replaced by more accurate tests. Viral load (RT-PCR, counting copies of HIV RNA) and CD4 counts follow a person on treatment.
Prevention.
- One faithful, uninfected partner; or condoms, every time.
- Blood and blood products screened before transfusion; a new, sterile needle for every injection, never shared.
- Testing every pregnant woman, and treatment for mothers with HIV in pregnancy, at delivery and while breastfeeding.
- Treatment as prevention: a person on treatment whose viral load is too low to measure does not pass HIV on through sex (“U = U”, undetectable = untransmittable).
- PrEP (pre-exposure prophylaxis), daily tablets for people at high risk, and PEP, tablets taken within 72 hours after an exposure.
Treatment. No cure yet, but antiretroviral therapy (ART), once called highly active antiretroviral therapy (HAART), keeps HIV in check for life: a combination of drugs that block different steps of its life cycle, so the virus can’t become resistant to all at once. The first drug, zidovudine (AZT, 1987), blocks reverse transcriptase; others are nevirapine (also a reverse transcriptase blocker), saquinavir (a protease blocker) and, most used today, dolutegravir (an integrase blocker), in one daily tablet with tenofovir and lamivudine. ART is free in Nepal. With it, a person with HIV can live about as long as anyone else.
Why is HIV common among people who inject drugs?
Pick an answer to see why.
IV. Typhoid
Introduction. Typhoid fever (typhoid; म्यादी ज्वरो, myadi jwaro, “the fever that runs its term”, in Nepali) is a life-threatening bacterial infection spread through contaminated food or water. Swallowed bacteria pass through the gut wall, multiply in the lymph tissue and the liver and spleen, and spread in the blood. Because it starts in the intestine, it is called enteric fever.
Description. Typhoid is acquired and communicable, a water-borne and food-borne disease, and a human-carrier disease: people are the bacterium’s only reservoir. It is endemic in Nepal, where poor sanitation lets sewage into drinking water. It is a physical disease of the intestine and, as it spreads, the whole body.
Epidemiology. Clean water, sewers and antibiotics made typhoid rare in industrialized countries during the 20th century. It is still common in South Asia, Southeast Asia, Africa, the Eastern Mediterranean, the Western Pacific and parts of South America, wherever safe water and toilets are lacking; children are at highest risk. The WHO estimates about 9 million cases and 110,000 deaths a year worldwide (2019). In Nepal enteric fever has long been among the commonest causes of fever in hospital, especially in the Kathmandu Valley in the pre-monsoon and monsoon. Crowded, growing cities, floods and antibiotic resistance threaten to make it worse.
Causative agent. Salmonella enterica serovar Typhi (Salmonella Typhi, S. typhi in older books): a Gram-negative, rod-shaped bacterium (bacillus) that moves with many flagella, and whose only natural host is the human being.
Mode of transmission. The feco-oral (or urino-oral) route: food or water contaminated with feces or urine from someone who is ill or a carrier. Flies carry it from feces to food.
Incubation period. Usually 6 to 30 days (most often 1 to 2 weeks).
Signs and symptoms. A high fever that climbs step by step over the first week (a step-ladder fever), with a severe headache, stomach pain, tiredness, loss of appetite, nausea and vomiting, and constipation or diarrhea. The pulse may be slower than such a fever would make it (relative bradycardia). Some people have faint pink rose spots on the chest and abdomen in the second week.
Effects. Untreated, in the third week the bacteria can ulcerate the lymph patches (Peyer’s patches) of the small intestine, causing intestinal bleeding or perforation (a hole in the gut), the most dangerous complication; others are sepsis (infection through the blood), inflammation of the liver, and, rarely, meningitis. Before modern tests, doctors saw the swollen red patches of the intestine only at a post-mortem.
Diagnosis.
- Blood culture in the first week, the most reliable test.
- An antibody test, the Widal test, from the second week; it is cheap but unreliable in places like Nepal where many people have met the bacterium before, so it can’t be trusted alone.
- Stool culture in the third week.
- Urine culture in the fourth week.
- Bone marrow culture, the most sensitive of all, when others fail.
Prevention. Safe drinking water, toilets and proper sanitation, hand washing with soap after the toilet and before food, healthy food (cooked and eaten hot; fruit peeled), health education, and vaccination. The typhoid conjugate vaccine (TCV), one injection, protects from 6 months of age to adulthood (it is approved up to 45 years). Nepal added TCV to its schedule in 2022, with a campaign that vaccinated more than seven million children; it is now given at 15 months.
Treatment. Antibiotics chosen after testing which ones the bacteria resist: azithromycin by mouth or ceftriaxone by injection; ciprofloxacin, once the standard, now fails against most typhoid bacteria in South Asia, and chloramphenicol, the first drug for typhoid (1948), is little used today. Resistance is a growing threat: since 2016 an extensively drug-resistant strain has spread in Pakistan.
A patient has had a fever for five days. Which test is most likely to find typhoid bacteria?
Pick an answer to see why.
V. Tuberculosis
Introduction. Tuberculosis (TB), also called Koch’s disease after the bacterium’s discoverer, is a bacterial infection that most often attacks the lungs, but can also attack the intestine, spine, skin, brain, kidneys and other organs. In Nepal it was once called राजरोग (rajarog, “the king of diseases”); now it is क्षयरोग (kshayarog, the wasting disease).
Description. TB is acquired (it is caught, not inherited: family members get it because they share air with a patient, not their genes); a baby can very rarely be born with it, from its mother through the placenta (congenital TB). It is communicable and air-borne, spread by the droplets a patient coughs out. It was pandemic in the 18th and 19th centuries, when the “white plague” caused about one death in four in Europe’s cities, and is endemic in Nepal and India today. It is a physical disease of the lungs and, in some patients, the spine, brain or kidneys. 24 March, the day in 1882 when Robert Koch announced the bacterium, is World TB Day.
Epidemiology. TB is the world’s deadliest infectious disease: in 2024 about 10.7 million people fell ill with it and 1.23 million died (WHO, 2025). About a quarter of all people carry the bacteria in a sleeping (latent) state; 5 to 10% of them will fall ill in their lifetime, more if their immunity weakens. India has the most cases, about a quarter of the world’s. In Nepal, the first national survey (2018–19) found TB far commoner than thought: about 117,000 people living with the disease, and about 69,000 falling ill each year. The WHO estimates that in 2024 about 67,000 people in Nepal fell ill with TB and about 16,000 died of it.
Risk factors. Overcrowding, poor ventilation, air pollution, poverty and undernourishment; working long hours in closed, dusty rooms, as in the carpet and garment factories; HIV and other conditions that weaken immunity; diabetes; and smoking and drinking alcohol.
Types of tuberculosis. By the part of the body it affects:
- Pulmonary TB: in the lungs and the pleura round them: the commonest form, and the one that spreads.
- Extrapulmonary TB: outside the lungs: abdominal TB; TB of the backbone (Pott’s spine), which can bend the back; TB of the skin (lupus vulgaris); TB of the tongue, of the lymph nodes, of the brain’s coverings (TB meningitis), and of the kidneys.
- Miliary TB: TB spread through the blood to many organs at once (lungs, liver, bone marrow, the meninges, the pericardium round the heart), named for the tiny lesions like millet seeds it leaves in them.
Causative agent. Mycobacterium tuberculosis, a slender, rod-shaped bacillus that doesn’t form spores or move, needs oxygen (it is an obligate aerobe, so it settles in the airy upper lobes of the lungs), divides slowly (once every 15 to 20 hours), and infects only people. Its waxy cell wall, full of mycolic acid, resists drying, many disinfectants and the Gram stain; it holds a red dye even when washed with acid, so it is called acid-fast, and is found in sputum by the Ziehl–Neelsen stain.
Mode of transmission. When a person with TB of the lungs coughs, sneezes, sings or talks, tiny droplet nuclei float in the air for hours; breathing in just a few bacilli can infect. TB of cattle spreads through infected cow’s milk.
Incubation period. From infection to a positive tuberculin test or the first lesion, about 3 weeks to 3 months; but most infected people never fall ill, and in others the disease starts years later.
Signs and symptoms. A cough lasting more than two weeks, coughing up blood (hemoptysis), weakness and tiredness, a low fever in the evenings, night sweats, loss of appetite (anorexia), chest pain and weight loss.
Effects. M. tuberculosis usually destroys parts of the lungs, leaving cavities; but it can also attack the abdomen, tongue, skin, spine, kidneys and brain, as listed above.
Diagnosis.
- Sputum tests: microscopy for acid-fast bacilli (two samples, one of them early in the morning); and, now widely used in Nepal, the GeneXpert test, an automated PCR that finds the bacterium’s DNA in two hours and shows whether it resists the drug rifampicin; and culture, which takes weeks.
- Mantoux (tuberculin) test: a little tuberculin injected into the skin of the forearm; a hard swelling after 2–3 days shows the person has met the bacterium (or had BCG).
- Chest X-ray: shadows and cavities in the upper lungs.
Prevention.
- See a health worker if a cough lasts more than two weeks; finding and treating patients early stops the spread.
- Keep rooms ventilated, and cover coughs; patients wear masks in the first weeks of treatment.
- BCG (Bacillus Calmette–Guérin) vaccine at birth: one injection into the skin of the upper arm. It protects babies and young children well against the severe forms, miliary TB and TB meningitis, though much less against TB of the lungs in adults.
- Drink boiled or pasteurized milk.
Treatment. Anti-tubercular treatment (ATT): several drugs together, because TB bacteria become resistant to any single drug. The first-line drugs are isoniazid (H), rifampicin (R), pyrazinamide (Z) and ethambutol (E); streptomycin (S), the first anti-TB drug (1943), is also used. Of these, ethambutol only stops the bacteria multiplying (bacteriostatic), while the others kill them (bactericidal). Streptomycin is the only one given by injection; the rest are tablets. Two side effects every patient is told about: rifampicin turns urine, sweat and tears orange-red (harmless), and isoniazid uses up vitamin B₆ (pyridoxine), which can inflame the nerves of the hands and feet (peripheral neuritis), so patients on it take vitamin B₆ as well.
The standard course for new patients lasts 6 months: an intensive phase of 2 months on all four drugs (HRZE), then a continuation phase of 4 months on two (HR), written 2HRZE/4HR.
Control measures: DOTS. Patients feel better within a few weeks and are tempted to stop, which leaves the toughest bacteria alive and breeds resistance. So the WHO’s strategy, directly observed treatment, short-course (DOTS), has a health worker or volunteer watch the patient swallow every dose, free of charge, with sputum checked during treatment and every case recorded. Nepal started DOTS in 1996 and had extended it to every district by 2001; its National Tuberculosis Control Center, at Thimi in Bhaktapur, runs the program.
Why is TB always treated with several drugs at once?
Pick an answer to see why.
VI. Cholera
Introduction and description. Cholera (हैजा, haija in Nepali) is an acute bacterial infection of the small intestine that causes sudden, massive, watery diarrhea and often vomiting, which can kill by dehydration within hours. It is a physical disease of the intestine; acquired; communicable, a water-borne and food-borne disease spread from person to person through contaminated water and food; and it has been pandemic seven times. 22 March is the United Nations’ World Water Day, which draws attention to safe water and sanitation, the way to prevent cholera.
Epidemiology. From its old home in the Ganges delta of India and Bangladesh, cholera spread across the world in 1817 in the first of seven pandemics, which killed millions on every continent through the 19th century. The seventh pandemic, still going on, began in Indonesia in 1961, reached Africa in 1971 and South America in 1991. Each year there are an estimated 1.3 to 4 million cases and 21,000 to 143,000 deaths (WHO), nearly all in places without safe water. Nepal has outbreaks in the monsoon most years, most often in the Kathmandu Valley.
Risk factors. Poor sanitation and unsafe water, a sick person in the household, eating raw or undercooked food (especially seafood), and low stomach acid (the acid kills most cholera bacteria; people taking antacids or with stomach disease are more at risk). People of blood group O tend to have more severe cholera, for reasons not fully known.
Causative agent. Vibrio cholerae, a short, comma-shaped (curved) Gram-negative rod with one flagellum at one end, which lets it dart about. It lives only in people and in coastal and brackish water. It was first seen by Filippo Pacini in Italy in 1854 and isolated in pure culture by Robert Koch in Egypt and India in 1883–84.
Causes and mode of transmission. The feco-oral route: water or food contaminated with the feces or vomit of a patient; raw or undercooked shellfish and other seafood; raw fruit and vegetables washed in dirty water.
Incubation period. Usually 12 hours to 5 days (most often 1–2 days). A patient passes the bacteria in the stool for about 1 to 10 days after infection, even when not ill.
Signs and symptoms. Most people infected have no or mild symptoms, but pass bacteria in their stools. In about one in ten, it starts suddenly with painless, watery diarrhea, pale and flecked like the water rice was washed in (rice-water stools), up to a liter an hour, with vomiting. The loss of water causes dehydration: tiredness, irritability, sunken eyes, a dry mouth, wrinkled skin that stays up when pinched, extreme thirst, little or no urine, an irregular, fast heartbeat and low blood pressure. The loss of salts, sodium and potassium (electrolyte imbalance) brings muscle cramps and shock. Children may also become very drowsy, with fever, convulsions and coma.
Effects. V. cholerae sticks to the lining of the small intestine but doesn’t invade it: all the damage is done by the cholera toxin (CTX) it releases. The toxin enters the gut-lining cells and switches on an enzyme that makes cyclic AMP without stopping; this keeps the cell’s chloride channels open, so chloride ions pour into the gut, sodium follows them, and water follows the salts by osmosis. The gut wall is not destroyed, which is why oral rehydration works.
Complications. Low blood sugar (hypoglycemia), low potassium (hypokalemia), and kidney failure from the low blood volume.
Diagnosis. A stool test: culture of the bacteria, and rapid dipstick tests used in outbreaks.
Prevention. Proper sanitation and toilets, hand washing with soap, safe drinking water (boiled, filtered or chlorinated), eating food cooked and hot, and avoiding raw food. Oral cholera vaccines (two doses of killed bacteria, by mouth) are given to people in or going to places of high transmission and during outbreaks; someone vaccinated long before who goes into an outbreak needs a booster.
Treatment.
- Oral rehydration salts (ORS) dissolved in clean water: most patients need nothing else. In Nepal, ORS is sold as Jeevan Jal.
- Other electrolyte solutions as supplements.
- Intravenous (IV) fluids for severe dehydration, when the patient can’t drink enough.
- Zinc tablets for children, which shorten the diarrhea.
- Antibiotics (doxycycline, azithromycin) for severe cases, to shorten the illness and the time bacteria are passed.
Cholera toxin causes diarrhea mainly by:
Pick an answer to see why.
VII. Candidiasis
Introduction. Candidiasis is a fungal infection caused by yeasts of the genus Candida, most often Candida albicans. Candida normally lives harmlessly on the skin and inside the body, in the mouth, throat, gut and vagina, kept in check by the body’s defenses and the bacteria around it. When that balance is upset, by antibiotics that kill the bacteria, by diabetes, by a weak immune system (HIV, cancer treatment, steroids), in babies and the elderly, or under dentures and in warm, moist skin folds, it overgrows and causes infection. In Nepal it is called खमिर सङ्क्रमण (khamir sankraman, yeast infection).
Description. Candidiasis is a physical disease of the skin and mucous membranes (mouth, throat, gut, vagina), and in severe cases of the whole body. It is acquired; a baby is very rarely born with it, but often picks it up from the mother at birth (oral thrush in newborns). It is communicable only in a limited way: most infections come from a person’s own Candida overgrowing, though it can pass between sexual partners, from mother to baby, and, for the resistant Candida auris, through hands and objects in hospitals. It occurs everywhere, at a steady level.
Epidemiology. Hippocrates, about 400 BCE, described white patches in the mouths of sick patients that were probably thrush. The fungus itself was described in the mid-1800s, and named Candida albicans (“shining white”) in 1954. Candidiasis is commonest in babies and old people. Bloodstream infection by Candida (candidemia) strikes about 9 in every 100,000 people a year in the USA; in hospitals it is one of the commonest bloodstream infections.
Types. By where it infects:
- Cutaneous candidiasis: on the skin, in warm, moist folds (armpits, under the breasts, the groin, between the buttocks; diaper rash in babies): a raised, red, itchy patch with small bumps.
- Vaginal candidiasis (yeast vaginitis): itching, burning, redness and a thick, white discharge. Very common: about three in four women have it at least once.
- Oral candidiasis (thrush): white patches in the mouth and throat; it may spread down the esophagus.
- Invasive (systemic) candidiasis: in the blood (candidemia), the heart’s lining, the brain’s coverings and other organs, in people already seriously ill or with very weak immunity; it can kill.
- Candida granuloma: a rare, severe, long-lasting form of chronic mucocutaneous candidiasis, with thick, crusted growths on the skin, scalp, mouth and nails, in people with an inherited weakness of immunity to Candida.
Causative agent. Candida albicans, a yeast that can grow as round budding cells or as long threads (hyphae) that push into tissue. It causes thrush in the mouth, vaginitis in the vagina, rashes in skin folds and infections of the nail beds.
Causes and mode of transmission. Mostly the person’s own Candida, from the skin, mouth, throat, gut and vagina, overgrowing. Passed on by direct contact (from mother to baby at birth, sometimes between sexual partners) or indirectly by contaminated hands and objects, mainly in hospitals.
Incubation period. Hard to define, since most infections come from yeast already in the body; oral thrush in a newborn appears about a week after birth.
Signs and symptoms.
- Cutaneous: intense itching; a red, spreading rash in skin folds, on the genitals, the middle of the body, the buttocks and under the breasts.
- Vaginal: itching and irritation of the vagina and vulva; burning, especially when passing urine or during sex; redness and swelling of the vulva; soreness and pain; a rash; a thick, white, odorless discharge like cottage cheese, or a watery one.
- Oral: white patches on the inner cheeks, tongue, roof of the mouth and throat, which leave red, sore spots when wiped; a cotton-like feeling in the mouth; loss of taste; pain when eating or swallowing; cracks and redness at the corners of the mouth.
- Invasive: fever and chills that don’t get better with antibiotics; a serious infection of the blood, the heart’s lining or the brain.
- Candida granuloma and nail infection: brittle, splitting nails, turning white, brown or yellow, with debris under them, thinning with a dry, powdery surface, and lifting off the nail bed.
Effects. From mild to severe: infection of the mouth (mostly the tongue); of the skin, genitals and nails; and, in invasive candidiasis, of internal organs.
Diagnosis. Usually by its look. A scraping or swab examined under the microscope (with potassium hydroxide, KOH, which clears the skin cells and shows the yeast and its threads) and cultured; for invasive candidiasis, blood culture, and blood tests for the fungus’s cell-wall sugar, mannan, and for antibodies against it (anti-mannan).
Prevention. Keeping skin folds clean and dry, cotton underwear, good mouth hygiene and cleaning dentures, rinsing the mouth after using a steroid inhaler, controlling diabetes, and using antibiotics only when needed; and in hospitals, hand washing and clean equipment.
Treatment. Antifungal drugs: creams, mouth gels or pessaries of clotrimazole or nystatin for skin, mouth and vaginal infections; tablets of fluconazole; and for invasive candidiasis, drugs given into a vein in hospital.
A patient finishes a week of a strong antibiotic and then develops white patches in her mouth. Why?
Pick an answer to see why.
3. Immunology: I. Immunity
Immunology is the study of the body’s resistance to infection: its immune system and the immunity it gives. (Vaccines, which make use of it, follow.)
Immunity (Latin immunis, exempt) is the body’s ability to resist foreign substances: viruses, bacteria, fungi, protozoa, parasites and their toxins. It is of two kinds: innate immunity, which we are born with, and acquired immunity, which develops after birth.
i. Innate immunity
Innate immunity, also called non-specific immunity, is present from birth and acts the same way against any invader, at once, with no memory. It has four kinds of defensive barrier.
- A. Physical and anatomical barriers, the first line of defense, keep pathogens out: the skin (layers of dead cells, dry and slightly acidic), the mucous membranes that line the airways, gut and other openings, with their sticky mucus and beating cilia, and sebum, the oil from the skin’s sebaceous glands, which kills some bacteria.
- B. Physiological barriers: body temperature (fever slows many pathogens), low pH (stomach acid at pH 1–3, the acid skin and vagina), and chemicals: lysozyme in tears, saliva and mucus, which splits bacterial cell walls; interferons, proteins that infected cells release to warn their neighbors against viruses; and complement, blood proteins that punch holes in bacteria.
- C. Phagocytic barriers: white blood cells that swallow and digest invaders (phagocytosis): neutrophils, and monocytes, which grow into macrophages in the tissues.
- D. Inflammatory barriers: at an injury or infection, damaged cells and mast cells release histamine, kinins and prostaglandins, which widen the blood vessels and make them leaky: the area becomes red, warm and swollen (edema), and phagocytes stream in.
ii. Acquired immunity
Acquired immunity, also called adaptive or specific immunity, develops after birth when the body meets a particular foreign substance, an antigen. Its four characteristics:
- Specificity: each response is aimed at one antigen.
- Diversity: it can respond to millions of different antigens.
- Memory: after the first meeting it remembers, and answers a second meeting faster and more strongly.
- Self and non-self recognition: it attacks foreign antigens and normally leaves the body’s own cells alone.
Its main cells are of two groups: lymphocytes (B cells, which mature in the bone marrow, and T cells, which mature in the thymus), and antigen-presenting cells (macrophages, dendritic cells and B cells), which show pieces of antigen to T cells. Its proteins are antibodies (immunoglobulins), Y-shaped proteins of five classes: IgG (the most common in blood, the only one that crosses the placenta), IgA (in tears, saliva, mucus and breast milk), IgM (the first made in a new infection), IgD (on B cells) and IgE (in allergies and against worms).
Phagocyte: Servier Medical Art (smart.servier.com), CC BY 4.0
Mariana Ruiz Villarreal, LadyofHats, Public domain, via Wikimedia Commons
Acquired immunity works in two ways.
- A. Humoral immunity (humor, a body fluid: plasma and lymph), also called antibody-mediated immunity: B cells, activated by their antigen and by helper T cells, multiply and become plasma cells, which release antibodies into the blood and lymph. Antibodies neutralize toxins, stop viruses from entering cells, and coat bacteria so phagocytes eat them. It acts against microbes and toxins in body fluids, outside cells.
- B. Cell-mediated immunity, also called cellular immunity: T cells act themselves, without antibodies. Cytotoxic (killer) T cells recognize and kill body cells infected by viruses, cancer cells and the cells of transplanted organs; helper T cells release cytokines that switch on B cells, killer T cells and macrophages.
Differences between humoral and cell-mediated immunity
| Humoral immunity | Cell-mediated immunity |
|---|---|
| carried out by B lymphocytes, through the antibodies they make (helped by helper T cells and macrophages) | carried out by T lymphocytes themselves: helper T cells, cytotoxic T cells, regulatory T cells, with macrophages and natural killer (NK) cells |
| plasma cells (effector B cells) release antibodies, which circulate as soluble proteins in blood and lymph; memory B cells remember | T cells don’t make antibodies; they kill infected cells directly or release cytokines |
| acts on microbes and toxins outside cells (in blood and tissue fluid) | acts on microbes inside cells (viruses, some bacteria and parasites) and on tumor cells |
| antibodies recognize antigens as they are, unprocessed | T cells recognize only antigen processed and presented on MHC proteins |
| fast once memory exists; causes immediate allergies | also causes delayed-type hypersensitivity (the tuberculin test’s swelling after 2–3 days) |
| does not destroy tumor cells or reject transplants | destroys tumor cells and rejects transplanted organs |
Active and passive immunity
By how it is obtained, immunity is active or passive.
- Active immunity: the body makes its own antibodies and memory cells, after an infection (natural) or a vaccine (artificial). It takes one to two weeks to build, but lasts long, often for life.
- Passive immunity: ready-made antibodies are received from someone else: from the mother across the placenta and in breast milk (natural), or by an injection of antibodies (artificial), such as anti-snake venom after a snakebite, or rabies immunoglobulin after a dog bite. It acts at once, but lasts only weeks to months, because the body makes no memory cells.
| Natural | Artificial | |
|---|---|---|
| Active (own antibodies, long-lasting) | after recovering from measles | after the measles vaccine |
| Passive (borrowed antibodies, short) | a baby’s antibodies from its mother | anti-snake venom; rabies immunoglobulin |
A farmer in Chitwan is bitten by a cobra and is given anti-snake venom. What kind of immunity does it give?
Pick an answer to see why.
3. Immunology: II. Vaccines
Vaccines are preparations of killed, inactivated, or weakened (attenuated) microorganisms, parts of microorganisms, inactivated toxins (toxoids), or the genes for their parts, which, when injected, swallowed or sprayed into the nose of a person or animal, produce immunity to a particular disease, without causing the disease.
Vaccination (also called immunization or inoculation) is the giving of a vaccine to stimulate the body to make antibodies and memory cells: it confers active immunity. Live weakened viruses are used against measles, mumps, rubella, chickenpox, yellow fever, polio (by mouth) and other viral diseases; killed bacteria against whooping cough, typhoid (an old vaccine) and cholera; and toxoids against diphtheria and tetanus.
History
People in China and India had protected themselves against smallpox for centuries by variolation: scratching material from a smallpox sore into a healthy person’s skin, which usually gave a milder illness and lifelong immunity, though it sometimes killed. The English doctor Edward Jenner (1749–1823) found a safer way.
The French scientist Louis Pasteur (1822–1895) made the first vaccine of weakened (attenuated) microbes in a laboratory: in 1879 he found that old cultures of the bacteria that cause chicken cholera no longer killed hens, and protected them against fresh ones. He went on to vaccines against anthrax (1881) and rabies (1885), and he proposed calling them all “vaccines” in honor of Jenner. So Jenner is remembered as the father of vaccination (and of immunology), and Pasteur as the father of microbiology, having laid the scientific basis of vaccination. Later, an inactivated toxin, the toxoid, was used for active immunity against diseases caused by toxins: tetanus, diphtheria and botulism.
World Immunization Week is held each year from 24 to 30 April by the WHO, to encourage vaccination against preventable diseases; some countries also mark a World Immunization Day on 10 November.
Vaccine preparation
The first vaccines were made by conventional (classical) methods: growing the whole microbe and then weakening it, killing it, or inactivating its toxin. Modern methods use biotechnology: making only the needed part of the microbe in yeast, bacteria or cell cultures by genetic engineering (recombinant vaccines), or delivering the gene for it. Such vaccines can be made faster, can’t cause the disease (they contain no whole microbe), and are more consistent from batch to batch. Every vaccine, old or new, is then tested in trials on thousands of people before it is licensed, and watched for rare side effects after.
Types of vaccines
By what they contain, vaccines are of six types.
| Type | What it contains | Examples |
|---|---|---|
| A. Live attenuated (whole-agent) | the living microbe, weakened so it multiplies a little without causing disease | oral polio (OPV, Sabin), measles, mumps, rubella (MMR, MR), BCG, rotavirus, chickenpox, yellow fever, Japanese encephalitis (the vaccine used in Nepal), nasal flu spray; vaccinia (related to cowpox) for smallpox |
| B. Inactivated (killed whole-agent) | the whole microbe, killed by heat or chemicals (formalin, phenol) | injected polio (IPV, Salk), whole-cell pertussis (in DTwP), rabies, hepatitis A, injected flu, oral cholera |
| C. Toxoid | the microbe’s toxin, inactivated | diphtheria, tetanus |
| D. Subunit | only the parts of the microbe that best stimulate immunity, often made by genetic engineering | hepatitis B (HBsAg), acellular pertussis (DTaP), HPV, the malaria vaccines RTS,S and R21 |
| E. Conjugate | a sugar (polysaccharide) coat of the bacterium joined to a protein, so that young children’s immune systems respond to it | Hib (Haemophilus influenzae type b), pneumococcal (PCV), typhoid conjugate (TCV) |
| F. Nucleic acid | the gene for an antigen, as DNA or mRNA, which the body’s own cells read to make the antigen | the mRNA COVID-19 vaccines (2020); a DNA COVID-19 vaccine licensed in India (2021); DNA and mRNA vaccines against malaria, HIV, flu, Ebola and herpes are being tested |
(A seventh type, viral vector vaccines, carries the gene inside a harmless virus: the Oxford–AstraZeneca COVID-19 vaccine, made in India as Covishield, was the first COVID-19 vaccine given in Nepal, from 27 January 2021, and Ervebo against Ebola.)
Generations of vaccines
Some books also group vaccines by how they are made into generations. Authors divide them a little differently; one common scheme:
- First generation: made by conventional methods from whole microbes, live attenuated, inactivated or killed, and toxoids: influenza, measles, mumps, polio, rabies, rotavirus, rubella, BCG (tuberculosis), typhoid, chickenpox (varicella), yellow fever, shingles (zoster), cholera, hepatitis A, whole-cell pertussis and plague.
- Second generation: recombinant subunit vaccines made by genetic engineering, such as the hepatitis B vaccine (1986), with the purified and conjugate vaccines.
- Third generation: genetic (nucleic acid) vaccines, DNA or mRNA, which make the body produce the antigen; the mRNA COVID-19 vaccines, and cancer vaccines now in trials.
- Fourth generation: designed by computer from the structure of a microbe’s receptor-binding parts, chemically or artificially made to block the infectious agent from binding to cells; some newer coronavirus vaccines and nanoparticle vaccines are of this kind, mostly still in trials.
Active and passive immunization
Every vaccine gives active immunity: whether it contains a whole microbe, a toxoid, a subunit, a sugar coat or a gene, the body makes its own antibodies and memory cells. Ready-made antibodies given by injection give passive immunity; strictly, they are not vaccines but antisera or immunoglobulins.
- Active immunization: any vaccine, from oral polio to the HPV vaccine.
- Passive immunization: anti-snake venom (ASV), rabies immunoglobulin (given with rabies vaccine after a deep dog bite), tetanus immunoglobulin, and antibodies against diphtheria toxin.
Which of these gives passive immunity?
Pick an answer to see why.
Vaccines protect more than the people who get them. A sick person passes an infection on to a certain number of others, its basic reproduction number, R₀, if nobody around is immune (about 2.5 for COVID-19 at first, 12 to 18 for measles). When enough people are immune that each case gives rise to fewer than one new case, the infection fades out, and even those who can’t be vaccinated, such as newborn babies and people with weak immunity, are protected. This is herd immunity. The share that must be immune is 1 − 1/R₀: 60% for R₀ = 2.5, but over 90% for measles, which is why measles comes back as soon as vaccination slips.
Vaccines against the major diseases
Some of the vaccines in use, especially in developing countries:
| Pathogen | Disease | Contains | Type | Vaccine | |
|---|---|---|---|---|---|
| 1. | measles virus | measles | whole microorganism | live attenuated | measles (in MR, MMR) |
| 2. | mumps virus | mumps | whole microorganism | live attenuated | mumps (in MMR) |
| 3. | varicella-zoster virus | chickenpox | whole microorganism | live attenuated | varicella |
| 4. | yellow fever virus | yellow fever | whole microorganism | live attenuated | yellow fever |
| 5. | poliovirus | poliomyelitis (polio) | whole microorganism | live attenuated; inactivated | oral polio (Sabin, by mouth); IPV (Salk, injected) |
| 6. | rubella virus | rubella (German measles) | whole microorganism | live attenuated | rubella (in MR, MMR) |
| 7. | influenza virus | influenza | whole virus or its parts | inactivated (also live, as a nasal spray) | influenza, against types A and B |
| 8. | hepatitis A virus | hepatitis A | whole microorganism | inactivated | hepatitis A |
| 9. | hepatitis B virus | hepatitis B | surface antigen (HBsAg), a purified protein | recombinant subunit | hepatitis B (in the pentavalent) |
| 10. | Corynebacterium diphtheriae | diphtheria | toxoid (purified, inactivated toxin) | toxoid | DPT (in the pentavalent); Td |
| 11. | Bordetella pertussis | pertussis (whooping cough) | whole microorganism; or purified parts | inactivated (whole cell); subunit (acellular) | DPT (in the pentavalent) |
| 12. | Clostridium tetani | tetanus | toxoid | toxoid | DPT (in the pentavalent); Td |
| 13. | Mycobacterium bovis, weakened | tuberculosis | whole microorganism | live attenuated | BCG (Bacillus Calmette–Guérin) |
| 14. | Salmonella Typhi | typhoid | sugar coat joined to a protein; or whole | conjugate (TCV); live attenuated (Ty21a, capsules) | typhoid |
| 15. | Bacillus anthracis | anthrax | a purified protein from the bacteria | subunit | anthrax (for people at work risk) |
| 16. | Vibrio cholerae | cholera | whole microorganism | inactivated | oral cholera |
| 17. | Yersinia pestis | plague | whole microorganism | inactivated | plague (no longer widely made) |
| 18. | Plasmodium falciparum | malaria | a surface protein of the parasite | recombinant subunit | RTS,S (Mosquirix, 2021) and R21 (2023) |
Nepal’s National Immunization Program
Nepal’s National Immunization Program (राष्ट्रिय खोप कार्यक्रम), run by the Ministry of Health and Population’s Family Welfare Division, gives these vaccines free to every child and pregnant woman. This is the government’s national schedule (राष्ट्रिय खोप तालिका) as of 2026:
| Visit | When | Vaccine | How and where it is given | Protects against |
|---|---|---|---|---|
| Pregnant women | Td (tetanus and diphtheria): two doses a month apart in the first pregnancy, one in each later pregnancy | into the muscle (intramuscular), left upper arm | tetanus in mother and newborn, and diphtheria | |
| 1 | At birth, as soon as possible | BCG | into the skin (intradermal), right upper arm | tuberculosis |
| 2 | 6 weeks | rotavirus 1; OPV 1; PCV 1; DPT-HepB-Hib (pentavalent) 1 | drops inside the cheek; two drops by mouth; into the muscle of the right thigh; into the muscle of the left thigh | rotavirus diarrhea; polio; pneumonia and other pneumococcal disease; diphtheria, whooping cough, tetanus, hepatitis B and Haemophilus influenzae type b |
| 3 | 10 weeks | rotavirus 2; OPV 2; PCV 2; DPT-HepB-Hib 2 | as at 6 weeks | as at 6 weeks |
| 4 | 14 weeks | OPV 3; fIPV 1 (fractional inactivated polio vaccine); DPT-HepB-Hib 3 | two drops by mouth; into the skin, right upper arm; into the muscle of the left thigh | polio; diphtheria, whooping cough, tetanus, hepatitis B, Hib |
| 5 | 9 months | fIPV 2; MR 1 (measles–rubella); PCV 3 | into the skin, right upper arm; under the skin (subcutaneous), left upper arm; into the muscle of the right thigh | polio; measles and rubella; pneumococcal disease |
| 6 | 12 months | JE (Japanese encephalitis) | under the skin, right thigh | Japanese encephalitis |
| 7 | 15 months | MR 2; TCV (typhoid conjugate vaccine) | under the skin, left upper arm; into the muscle of the left thigh | measles and rubella; typhoid |
| 8 | Girls in Grade 6 (and girls of 10 not in school) | HPV | into the muscle of the left upper arm | cancer of the cervix |
Nepal began immunizing children in 1979. The HPV vaccine was added in February 2025 with a campaign that reached about 1.46 million girls in Grades 6 to 10, and since then is given each year to girls in Grade 6.
Exercise
The exercise for this unit and the next is one set; the questions on microbial diseases, immunity and vaccines are here, and those on the uses of microbes are at the end of Unit 29.
A. Tick the correct alternative
- Microbial diseases are diseases caused by:
Pick an answer to see why.
- Which risk group (RG) of microorganisms does not cause disease in healthy people?
Pick an answer to see why.
- Which virus is in RG-4?
Pick an answer to see why.
- Biosafety level 2 (BSL-2) is for which risk group?
Pick an answer to see why.
- Risk group 3 (RG-3) microorganisms fall in which hazard group (HG)?
Pick an answer to see why.
- Which biosafety level (BSL) is required for RG-2 microorganisms or HG-2 pathogens?
Pick an answer to see why.
- Diseases are grouped as non-communicable and communicable. Which group of diseases is communicable?
Pick an answer to see why.
- Which set contains bacterial diseases only?
Pick an answer to see why.
- Which disease is caused by a virus?
Pick an answer to see why.
- Which form of viral hepatitis is the most severe?
Pick an answer to see why.
- What happens to the immune system of a person with HIV/AIDS?
Pick an answer to see why.
- Which statement about HIV/AIDS is incorrect?
Pick an answer to see why.
- What is the causative agent of typhoid?
Pick an answer to see why.
- Which is a very common air-borne disease?
Pick an answer to see why.
- What is the causative agent of tuberculosis?
Pick an answer to see why.
- Which is a serious microbial disease that kills more than a million people a year?
Pick an answer to see why.
- Sudden, severe watery diarrhea and vomiting are the main symptoms of:
Pick an answer to see why.
- Which infection can pass between partners in sexual contact, and from mother to baby at birth?
Pick an answer to see why.
- Which drug is used specifically against candidiasis?
Pick an answer to see why.
- Vaccines are given in order to:
Pick an answer to see why.
- Which is a second-generation vaccine?
Pick an answer to see why.
B. Short answer questions
Summarize the risk groups, biosafety levels and hazard groups of microbes or pathogens.
Answer
Describe the epidemiology of influenza: its incidence, distribution, risk factors and control.
Answer
Write a short note on hepatitis B.
Answer
Sum up candidiasis in human beings.
Answer
What is immunity? Explain its types.
Answer
What are vaccines and vaccination? Describe the types of vaccines.
Answer
C. Long answer questions
What is disease? What is a microbial disease? What are risk, hazard and safety levels in terms of microorganisms? Discuss the risk and hazard groups of microorganisms, with the biosafety levels.
Answer
Name the causative agent of HIV/AIDS. Why is it common among people who inject drugs? Which parts or organs of the body are badly affected? Describe the mode of transmission, symptoms and prevention of HIV/AIDS.
Answer
Name the causative agent of typhoid. Explain its mode of transmission, symptoms and control measures, and name the parts or organs badly affected in severe cases.
Answer
Discuss the causes, causative agent, mode of transmission, effects, symptoms and control measures of tuberculosis. Relate DOTS to it.
Answer
Why is cholera called a microbial, physical, acquired, communicable, pandemic and water-borne disease? Describe its epidemiology, causative agent, causes, mode of transmission, incubation period, signs and symptoms, effects, diagnosis, prevention and control.
Answer
Printable PDFs
- Study notes 6 pages
- Worksheet 4 pages Answer key
Quiz yourself: Life Processes and the Human Body, Grades 5–12 →
Practice every question in the book, and keep track of the ones you miss →
A companion to your textbook, not a replacement for it: study from the book your school uses, and where the two differ, follow your teacher. Found a mistake? Please tell us.
